These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 1749421)
1. FDA vs. free speech over drug promotions. Anderson C Nature; 1991 Dec; 354(6353):421. PubMed ID: 1749421 [No Abstract] [Full Text] [Related]
2. Commentary: can we talk? About Food and Drug Regulation and the First Amendment. Cohen MN Food Drug Law J; 2003; 58(4):741-56. PubMed ID: 15027458 [No Abstract] [Full Text] [Related]
3. Pharmaceuticals and medical devices: FDA oversight. Chaps NA Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718 [No Abstract] [Full Text] [Related]
4. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003. Cowden AL; Katz KA Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900 [TBL] [Abstract][Full Text] [Related]
5. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief. Chaps NA Issue Brief Health Policy Track Serv; 2008 Jan; ():1-18. PubMed ID: 18345557 [No Abstract] [Full Text] [Related]
6. FDA tightens rules on advertising. Josefson D BMJ; 1997 Aug; 315(7106):447. PubMed ID: 9284658 [No Abstract] [Full Text] [Related]
7. FDA considers tightening regulations for direct-to-consumer advertising. Vastag B J Natl Cancer Inst; 2005 Dec; 97(24):1806-7. PubMed ID: 16368941 [No Abstract] [Full Text] [Related]
8. FDA finalizing policy statement on industry-supported activities. Am J Hosp Pharm; 1993 Mar; 50(3):391. PubMed ID: 8442443 [No Abstract] [Full Text] [Related]
9. Major issues in marketing regulation. Pines WL Food Drug Law J; 1997; 52(3):297-302. PubMed ID: 10343028 [No Abstract] [Full Text] [Related]
10. Drug firms back-pedal on direct advertising. Nature; 2005 Aug; 436(7053):910-1. PubMed ID: 16107811 [No Abstract] [Full Text] [Related]
11. US aims to tighten rules on direct-to-consumer drug ads. Vastag B Nat Biotechnol; 2007 Mar; 25(3):267. PubMed ID: 17344868 [No Abstract] [Full Text] [Related]
12. Drug risks and free speech--can Congress ban consumer drug ads? Shuchman M N Engl J Med; 2007 May; 356(22):2236-9. PubMed ID: 17476002 [No Abstract] [Full Text] [Related]
13. The new drug marketing: a consumer protection perspective. Woodward D Food Drug Law J; 1996; 51(4):637-50. PubMed ID: 11797733 [No Abstract] [Full Text] [Related]
15. Advertisements. FDA orders Abbott to change misleading ads for Norvir. AIDS Policy Law; 2004 Jul; 19(12):9. PubMed ID: 15282864 [No Abstract] [Full Text] [Related]
16. Drug manufacturers' First Amendment right to advertise and promote their products for off-label use: avoiding a pyrrhic victory. Blackwell AE; Beck JM; Food Drug Law J; 2003; 58(3):439-62. PubMed ID: 14626985 [No Abstract] [Full Text] [Related]
17. FDA questions San Francisco HIV/AIDS drug advertisements. AIDS Policy Law; 2001 May; 16(9):1, 6. PubMed ID: 11668819 [No Abstract] [Full Text] [Related]
18. Hearing shines spotlight on biosimilar controversies. Mullard A Nat Rev Drug Discov; 2010 Dec; 9(12):905-6. PubMed ID: 21119720 [No Abstract] [Full Text] [Related]
19. FDA investigates direct to consumer adverts. Lenzer J BMJ; 2005 Nov; 331(7525):1102. PubMed ID: 16282396 [No Abstract] [Full Text] [Related]
20. FDA considers effects of managed care marketplace on drug promotional practices. Wechsler J Formulary; 1995 Dec; 30(12):840-1. PubMed ID: 10153083 [No Abstract] [Full Text] [Related] [Next] [New Search]